CDH22 hypermethylation is an independent prognostic biomarker in breast cancer

  1. Martín-Sánchez, E.
  2. Mendaza, S.
  3. Ulazia-Garmendia, A.
  4. Monreal-Santesteban, I.
  5. Córdoba, A.
  6. Vicente-García, F.
  7. Blanco-Luquin, I.
  8. De La Cruz, S.
  9. Aramendia, A.
  10. Guerrero-Setas, D.
Journal:
Clinical Epigenetics

ISSN: 1868-7083,  1868-7075

Year of publication: 2017

Volume: 9

Issue: 1

Type: Article

DOI: 10.1186/S13148-016-0309-Z GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus